Immunotherapy Advances (IA)
Journal Descriptions
Immunotherapy Advances publishes scientifically rigorous research relating to manipulations of the immune system for the benefit of human and animal health in all disease areas. The journal covers the translational pipeline for immunotherapy from discovery research and preclinical animal models through to clinical trials. Experimental medicine and first-in-human clinical studies are encouraged, and negative clinical trials are welcomed where they contribute to immune-mechanistic insight. We also recognise the growing importance of interdisciplinary working in this area and encourage studies that are at the interface with engineering, mathematics and computer science, chemistry and the physical sciences.
Immunotherapy Advances (IA) is :-
-
International, Peer-Reviewed, Open Access, Refereed, Immunotherapy, Mathematics, Computer Science, Chemistry, Physical sciences , Online , Monthly Journal
- UGC Approved, ISSN Approved: P-ISSN E-ISSN: 2732-4303, Established: 2021, Impact Factor: 4.1
- Does Not Provide Crossref DOI
-
Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE